As a Clinical R&D Project Manager at Plus Therapeutics, a publicly traded radiopharmaceutical company, I coordinate and oversee various tasks related to new and ongoing phase 1/2 clinical trials for rare and difficult-to-treat CNS cancers. I work with a multidisciplinary team of scientists, clinicians, and vendors to ensure the quality and timeliness of our projects, from site start-up to data collection and analysis.I have a Master of Science in Clinical Research Management from UNT Health Science Center, where I conducted a thesis on biodegradable alginate microspheres containing Rhenium-188 radioisotopes for hepatic trans-arterial radioembolization (TARE). I also have a Bachelor of Science in Animal Sciences from Auburn University, where I received multiple scholarships and awards for my academic excellence and research involvement. I am passionate about advancing the field of radiation oncology and improving the lives of patients with challenging conditions.